NEW HORIZ.HEAL. DL-00005 (F:6YZ) — Market Cap & Net Worth
Market Cap & Net Worth: NEW HORIZ.HEAL. DL-00005 (6YZ)
NEW HORIZ.HEAL. DL-00005 (F:6YZ) has a market capitalization of $757.17 Million (€647.65 Million) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #10437 globally and #1220 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NEW HORIZ.HEAL. DL-00005's stock price €1.62 by its total outstanding shares 448718016 (448.72 Million).
NEW HORIZ.HEAL. DL-00005 Market Cap History: 2021 to 2026
NEW HORIZ.HEAL. DL-00005's market capitalization history from 2021 to 2026. Data shows change from $1.29 Billion to $849.85 Million (-14.91% CAGR).
NEW HORIZ.HEAL. DL-00005 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NEW HORIZ.HEAL. DL-00005's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6YZ by Market Capitalization
Companies near NEW HORIZ.HEAL. DL-00005 in the global market cap rankings as of May 5, 2026.
Key companies related to NEW HORIZ.HEAL. DL-00005 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
NEW HORIZ.HEAL. DL-00005 Historical Marketcap From 2021 to 2026
Between 2021 and today, NEW HORIZ.HEAL. DL-00005's market cap moved from $1.29 Billion to $ 849.85 Million, with a yearly change of -14.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €849.85 Million | 0.00% |
| 2025 | €849.85 Million | 0.00% |
| 2024 | €849.85 Million | -36.22% |
| 2023 | €1.33 Billion | +33.68% |
| 2022 | €996.74 Million | -22.76% |
| 2021 | €1.29 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of NEW HORIZ.HEAL. DL-00005 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $757.17 Million USD |
| MoneyControl | $757.17 Million USD |
| MarketWatch | $757.17 Million USD |
| marketcap.company | $757.17 Million USD |
| Reuters | $757.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NEW HORIZ.HEAL. DL-00005
New Horizon Health Limited, an investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People's Republic of China. Its products include ColoClear, an early screening products for colon cancer; Pupu Tube, a fecal occult blood self test product; and UU Tube, a helicobacter pylori self-test products. The com… Read more